Humacyte (HUMA) Assets (2020 - 2026)
Humacyte (HUMA) posted quarterly Assets of $110.6 million for Q1 2026, down 31.99% year-over-year from $162.6 million in Q1 2025, and down 4.99% quarter-over-quarter from $116.4 million in Q4 2025.
Humacyte (HUMA) Assets (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Assets for 7 consecutive years, with $110.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 31.99% year-over-year to $110.6 million; the TTM figure through Mar 2026 stood at $110.6 million (down 31.99% YoY), while the FY2025 annual figure was $116.4 million, down 15.6% from the prior year.
- Assets slipped to $110.6 million in Q1 2026 per HUMA's latest filing, from $116.4 million in the prior quarter.
- Across five years, Assets topped out at $264.5 million in Q1 2022 and bottomed at $91.5 million in Q3 2025.
- Historically, Assets has averaged $161.3 million across 5 years, with a median of $149.4 million in 2023.
- Annual changes were most pronounced in 2022 — Assets soared 162.71% — and 2023, when it plunged 37.24%.
- Humacyte's Assets stood at $204.3 million in 2022, then slumped by 37.24% to $128.2 million in 2023, then advanced by 7.53% to $137.9 million in 2024, then retreated by 15.6% to $116.4 million in 2025, then declined by 4.99% to $110.6 million in 2026.
- Business Quant data shows HUMA's Assets at $110.6 million in Q1 2026, $116.4 million in Q4 2025, and $91.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.57 Bn | 131.72 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 65.44 Bn | 60.25 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 60.06 Bn | 54.93 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.89 Bn | 28.58 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.11 Bn | 9.72 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Humacyte | 154.98 Mn | 154.98 Mn | -825,000.00 | 138.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 138.09 Mn |
| Mar 31, 2026 | 110.56 Mn |
| Dec 31, 2025 | 116.37 Mn |
| Sep 30, 2025 | 91.51 Mn |
| Jun 30, 2025 | 138.80 Mn |
| Mar 31, 2025 | 162.55 Mn |
| Dec 31, 2024 | 137.87 Mn |
| Sep 30, 2024 | 114.76 Mn |
| Jun 30, 2024 | 138.28 Mn |
| Mar 31, 2024 | 161.47 Mn |
| Dec 31, 2023 | 128.22 Mn |
| Sep 30, 2023 | 149.39 Mn |
| Jun 30, 2023 | 168.11 Mn |
| Mar 31, 2023 | 182.98 Mn |
| Dec 31, 2022 | 204.30 Mn |
| Sep 30, 2022 | 226.22 Mn |
| Jun 30, 2022 | 246.37 Mn |
| Mar 31, 2022 | 264.47 Mn |
| Dec 31, 2021 | 286.53 Mn |
| Sep 30, 2021 | 303.36 Mn |